Handelsbanken Fonder Ab Maravai Lifesciences Holdings, Inc. Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
A detailed history of Handelsbanken Fonder Ab transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 44,600 shares of MRVI stock, worth $317,106. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,600
Previous 32,900
35.56%
Holding current value
$317,106
Previous $236,000
57.2%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MRVI
# of Institutions
223Shares Held
124MCall Options Held
176KPut Options Held
2.2K-
12 West Capital Management LP New York, NY13.2MShares$93.9 Million9.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$76.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$69.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT9.02MShares$64.2 Million2.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$42.4 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $935M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...